Table 3 Hazard ratios (HR) of all-cause deaths, with corresponding 95% confidence intervals (CI), among 80 cases of colorectal cancers diagnosed in 2005–2006 in the Gaza Strip according to clinical characteristics
From: Survival after the diagnosis of breast or colorectal cancer in the GAZA Strip from 2005 to 2014
Cases | Deaths (N = 46) | ||
|---|---|---|---|
N | N (%) | HR (95% CI)a | |
Age at diagnosis (years) | |||
< 60 | 44 | 23 (52.3) | 1b |
≥ 60 | 36 | 23 (63.9) | 1.38 (0.77–2.48) |
Sex | |||
Male | 32 | 20 (62.5) | 1 |
Female | 48 | 26 (54.2) | 0.88 (0.48–1.59) |
Stage c | |||
Localized | 27 | 10 (37.0) | 1b |
Regional/Distant | 49 | 35 (71.4) | 3.38 (1.57–7.29) |
Grade c | |||
Well and moderately differentiated | 53 | 23 (43.4) | 1b |
Poorly differentiated and Undifferentiated | 22 | 19 (86.4) | 3.57 (1.87–6.81) |
Surgery | |||
No | 9 | 9 (100.0) | 1b |
Yes | 71 | 37 (52.1) | 0.27 (0.13–0.62) |
Chemotherapy | |||
No | 10 | 8 (80.0) | 1b |
Yes | 70 | 38 (54.3) | 0.37 (0.16–0.87) |
Radiotherapy | |||
No | 58 | 38 (65.5) | 1b |
Yes | 22 | 8 (36.4) | 0.24 (0.10–0.56) |
Number Therapies | |||
0–1 | 18 | 16 (88.9) | 1b |
2 | 40 | 22 (55.0) | 0.36 (0.17–0.74) |
3 | 22 | 8 (36.4) | 0.11 (0.04–0.31) |